BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

University of Georgia

Headquarters: Athens, GA, United States
Year Founded: 1785
Status: Non-biopharma

Biopharma related deals can be found by searching the organization's name in the Deals Module.

BioCentury | Sep 7, 2023
Product Development

ARPA-H supports a new side of mRNA research

Emory-led project gains ARPA-H backing to control immune cell function
BioCentury | Dec 5, 2019
Emerging Company Profile

VaxNewMo: bioconjugating antibacterial vaccines

VaxNewMo’s platform could yield new, less costly glycoconjugate vaccines
BioCentury | May 2, 2019
Emerging Company Profile

SAB: Human polyclonal antibodies on the hoof

SAB uses cows, goats to overcome limitations of generating polyclonal antibodies
BioCentury | Jan 3, 2019
Distillery Therapeutics

Infectious disease

BioCentury | Jan 4, 2018
Translation in Brief

ArunA’s exosome entrance

Why ArunA decided to develop exosome therapeutics for stroke
BioCentury | Sep 22, 2017
Politics, Policy & Law

Conferred immunity in IPR

Why Allergan’s purchase of sovereign immunity from an Indian tribe could end IPR
BioCentury | Aug 14, 2014
Distillery Therapeutics

Indication: Cancer

BioCentury | Mar 24, 2014
Strategy

The price of success

How payers hope to gain price leverage over new HCV drugs like Gilead's Sovaldi
BioCentury | Mar 17, 2014
Emerging Company Profile

Partikula: Mitochondrial delivery

Partikula delivering chemotherapeutics into mitochondria of cancer cells
Items per page:
1 - 10 of 51